Literature DB >> 22508697

INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells.

Christelle Morris1, Nozomi Tomimatsu, Derek J Richard, David Cluet, Sandeep Burma, Kum Kum Khanna, Pierre Jalinot.   

Abstract

Altered expression of the INT6 gene, encoding the e subunit of the translational initiation factor eIF3, occurs in human breast cancers, but how INT6 relates to carcinogenesis remains unestablished. Here, we show that INT6 is involved in the DNA damage response. INT6 was required for cell survival following γ-irradiation and G(2)-M checkpoint control. RNA interference-mediated silencing of INT6 reduced phosphorylation of the checkpoint kinases CHK1 and CHK2 after DNA damage. In addition, INT6 silencing prevented sustained accumulation of ataxia telangiectasia mutated (ATM) at DNA damage sites in cells treated with γ-radiation or the radiomimetic drug neocarzinostatin. Mechanistically, this result could be explained by interaction of INT6 with ATM, which together with INT6 was recruited to the sites of DNA damage. Finally, INT6 silencing also reduced ubiquitylation events that promote retention of repair proteins at DNA lesions. Accordingly, accumulation of the repair factor BRCA1 was defective in the absence of INT6. Our findings reveal unexpected and striking connections of INT6 with ATM and BRCA1 and suggest that the protective action of INT6 in the onset of breast cancers relies on its involvement in the DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508697      PMCID: PMC3335344          DOI: 10.1158/0008-5472.CAN-11-2562

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Evidence for the transforming activity of a truncated Int6 gene, in vitro.

Authors:  S B Rasmussen; E Kordon; R Callahan; G H Smith
Journal:  Oncogene       Date:  2001-08-30       Impact factor: 9.867

2.  Association of the mammalian proto-oncoprotein Int-6 with the three protein complexes eIF3, COP9 signalosome and 26S proteasome.

Authors:  Karine Hoareau Alves; Valérie Bochard; Stéphane Réty; Pierre Jalinot
Journal:  FEBS Lett       Date:  2002-09-11       Impact factor: 4.124

3.  Global quantification of mammalian gene expression control.

Authors:  Björn Schwanhäusser; Dorothea Busse; Na Li; Gunnar Dittmar; Johannes Schuchhardt; Jana Wolf; Wei Chen; Matthias Selbach
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

4.  The human protein HSPC021 interacts with Int-6 and is associated with eukaryotic translation initiation factor 3.

Authors:  C Morris-Desbois; S Réty; M Ferro; J Garin; P Jalinot
Journal:  J Biol Chem       Date:  2001-10-04       Impact factor: 5.157

5.  Reduced expression of INT-6/eIF3-p48 in human tumors.

Authors:  A Marchetti; F Buttitta; S Pellegrini; G Bertacca; R Callahan
Journal:  Int J Oncol       Date:  2001-01       Impact factor: 5.650

6.  Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Authors:  Hanne Meijers-Heijboer; Ans van den Ouweland; Jan Klijn; Marijke Wasielewski; Anja de Snoo; Rogier Oldenburg; Antoinette Hollestelle; Mark Houben; Ellen Crepin; Monique van Veghel-Plandsoen; Fons Elstrodt; Cornelia van Duijn; Carina Bartels; Carel Meijers; Mieke Schutte; Lesley McGuffog; Deborah Thompson; Douglas Easton; Nayanta Sodha; Sheila Seal; Rita Barfoot; Jon Mangion; Jenny Chang-Claude; Diana Eccles; Rosalind Eeles; D Gareth Evans; Richard Houlston; Victoria Murday; Steven Narod; Tamara Peretz; Julian Peto; Catherine Phelan; Hong Xiang Zhang; Csilla Szabo; Peter Devilee; David Goldgar; P Andrew Futreal; Katherine L Nathanson; Barbara Weber; Nazneen Rahman; Michael R Stratton
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

7.  Dominant negative ATM mutations in breast cancer families.

Authors:  Georgia Chenevix-Trench; Amanda B Spurdle; Magtouf Gatei; Helena Kelly; Anna Marsh; Xiaoqing Chen; Karen Donn; Margaret Cummings; Dale Nyholt; Mark A Jenkins; Clare Scott; Gulietta M Pupo; Thilo Dörk; Regina Bendix; Judy Kirk; Katherine Tucker; Margaret R E McCredie; John L Hopper; Joseph Sambrook; Graham J Mann; Kum Kum Khanna
Journal:  J Natl Cancer Inst       Date:  2002-02-06       Impact factor: 13.506

8.  Germline 657del5 mutation in the NBS1 gene in breast cancer patients.

Authors:  Bohdan Górski; Tadeusz Debniak; Bartlomiej Masojć; Marek Mierzejewski; Krzysztof Medrek; Cezary Cybulski; Anna Jakubowska; Grzegorz Kurzawski; Maria Chosia; Rodney Scott; Jan Lubiński
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

Review 9.  Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time.

Authors:  Jiri Lukas; Claudia Lukas; Jiri Bartek
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

10.  Cell cycle-related variation in subcellular localization of eIF3e/INT6 in human fibroblasts.

Authors:  S J Watkins; C J Norbury
Journal:  Cell Prolif       Date:  2004-04       Impact factor: 6.831

View more
  9 in total

1.  Unlike for cellular mRNAs and other viral internal ribosome entry sites (IRESs), the eIF3 subunit e is not required for the translational activity of the HCV IRES.

Authors:  Baptiste Panthu; Solène Denolly; Cendrine Faivre-Moskalenko; Théophile Ohlmann; François-Loïc Cosset; Pierre Jalinot
Journal:  J Biol Chem       Date:  2020-01-12       Impact factor: 5.157

2.  INT6/EIF3E Controls the RNF8-Dependent Ubiquitylation Pathway and Facilitates DNA Double-Strand Break Repair in Human Cells.

Authors:  Christelle Morris; Nozomi Tomimatsu; Sandeep Burma; Pierre Jalinot
Journal:  Cancer Res       Date:  2016-08-22       Impact factor: 12.701

3.  Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.

Authors:  Julie Sesen; Anne Cammas; Sarah J Scotland; Bertand Elefterion; Anthony Lemarié; Stefania Millevoi; Lijoy K Mathew; Cathy Seva; Christine Toulas; Elizabeth Cohen-Jonathan Moyal; Nicolas Skuli
Journal:  Int J Mol Sci       Date:  2014-01-29       Impact factor: 5.923

4.  Meta-analysis of DNA double-strand break response kinetics.

Authors:  Jakub A Kochan; Emilie C B Desclos; Ruben Bosch; Luna Meister; Lianne E M Vriend; Haico van Attikum; Przemek M Krawczyk
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

5.  Decreased expression of the translation factor eIF3e induces senescence in breast cancer cells via suppression of PARP1 and activation of mTORC1.

Authors:  Christelle Morris; Sébastien Durand; Pierre Jalinot
Journal:  Oncotarget       Date:  2021-03-30

6.  RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy.

Authors:  Waleed Iqbal; Elena V Demidova; Samantha Serrao; Taha ValizadehAslani; Gail Rosen; Sanjeevani Arora
Journal:  Front Genet       Date:  2021-03-12       Impact factor: 4.599

Review 7.  Localization and Functional Roles of Components of the Translation Apparatus in the Eukaryotic Cell Nucleus.

Authors:  Zaur M Kachaev; Sergey D Ivashchenko; Eugene N Kozlov; Lyubov A Lebedeva; Yulii V Shidlovskii
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

8.  Utilisation of semiconductor sequencing for detection of actionable fusions in solid tumours.

Authors:  Marco Loddo; Keeda-Marie Hardisty; Alexander Llewelyn; Tiffany Haddow; Robert Thatcher; Gareth Williams
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

9.  Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation.

Authors:  Daichi Sadato; Tomio Ono; Saki Gotoh-Saito; Naoki Kajiwara; Namiko Nomura; Masako Ukaji; Liying Yang; Kenji Sakimura; Youichi Tajima; Keisuke Oboki; Futoshi Shibasaki
Journal:  FEBS Open Bio       Date:  2018-07-05       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.